CN102000123B - 银杏黄酮胶囊及其制备方法 - Google Patents
银杏黄酮胶囊及其制备方法 Download PDFInfo
- Publication number
- CN102000123B CN102000123B CN2010105471703A CN201010547170A CN102000123B CN 102000123 B CN102000123 B CN 102000123B CN 2010105471703 A CN2010105471703 A CN 2010105471703A CN 201010547170 A CN201010547170 A CN 201010547170A CN 102000123 B CN102000123 B CN 102000123B
- Authority
- CN
- China
- Prior art keywords
- capsule
- gram
- hypromellose
- hyprolose
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930003944 flavone Natural products 0.000 title claims abstract description 35
- 235000011949 flavones Nutrition 0.000 title claims abstract description 35
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 title claims abstract description 33
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 150000002212 flavone derivatives Chemical class 0.000 title claims abstract description 32
- 241000218628 Ginkgo Species 0.000 title claims abstract description 30
- 235000011201 Ginkgo Nutrition 0.000 title claims abstract description 30
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 30
- 239000002775 capsule Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011347 resin Substances 0.000 claims abstract description 14
- 229920005989 resin Polymers 0.000 claims abstract description 14
- 239000000284 extract Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 239000000047 product Substances 0.000 claims abstract description 7
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 claims description 28
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 claims description 28
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 claims description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 26
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 24
- 244000194101 Ginkgo biloba Species 0.000 claims description 21
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 17
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 17
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 17
- 229960003943 hypromellose Drugs 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N lactose group Chemical group OC1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O2)CO)[C@H](O1)CO GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 15
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 13
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 13
- 229950005770 hyprolose Drugs 0.000 claims description 13
- 239000008101 lactose Substances 0.000 claims description 13
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- 235000019359 magnesium stearate Nutrition 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 10
- 235000012239 silicon dioxide Nutrition 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- -1 leaves standstill Substances 0.000 claims description 9
- 230000001476 alcoholic effect Effects 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 229960001375 lactose Drugs 0.000 claims description 6
- 229940057948 magnesium stearate Drugs 0.000 claims description 6
- 229960001866 silicon dioxide Drugs 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 5
- 239000008213 purified water Substances 0.000 claims description 5
- 238000001179 sorption measurement Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 abstract description 9
- 150000002596 lactones Chemical class 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 238000001914 filtration Methods 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229930182486 flavonoid glycoside Natural products 0.000 description 3
- 150000007955 flavonoid glycosides Chemical class 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 108010003541 Platelet Activating Factor Proteins 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105471703A CN102000123B (zh) | 2010-11-17 | 2010-11-17 | 银杏黄酮胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105471703A CN102000123B (zh) | 2010-11-17 | 2010-11-17 | 银杏黄酮胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102000123A CN102000123A (zh) | 2011-04-06 |
CN102000123B true CN102000123B (zh) | 2012-11-28 |
Family
ID=43807991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105471703A Active CN102000123B (zh) | 2010-11-17 | 2010-11-17 | 银杏黄酮胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102000123B (zh) |
-
2010
- 2010-11-17 CN CN2010105471703A patent/CN102000123B/zh active Active
Non-Patent Citations (2)
Title |
---|
何琦,等.D140大孔吸附树脂银杏黄酮提取纯化性能研究.《天然产物研究与开发》.2001,第13卷(第1期),第56-58页"2 结果与分析". |
何琦,等.D140大孔吸附树脂银杏黄酮提取纯化性能研究.《天然产物研究与开发》.2001,第13卷(第1期),第56-58页"2 结果与分析". * |
Also Published As
Publication number | Publication date |
---|---|
CN102000123A (zh) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101336987B (zh) | 一种枳椇总黄酮的制备方法 | |
CN101336978B (zh) | 一种北枳椇总黄酮的提取方法 | |
CN1931205B (zh) | 罗布麻属植物罗布麻叶总黄酮提取物、其制备及应用 | |
CN100469774C (zh) | 一种银杏叶提取物及该提取物高纯度有效成分的分离生产方法 | |
CN101585885A (zh) | 一种玉竹多糖的制备方法 | |
CN104523771A (zh) | 一种银杏叶总黄酮及其制备方法 | |
CN103169788B (zh) | 大枣叶提取物及其在制备防治肝损伤药物及保健食品中的应用 | |
CN101214253B (zh) | 知母皂苷b-ⅱ用于制备抗抑郁产品的用途 | |
CN104982597B (zh) | 一种多功能复合速溶茶及其制备方法和用途 | |
CN104211690B (zh) | 一种从白木香树叶中分离纯化芒果苷的方法 | |
CN100556433C (zh) | 复合型高儿茶素茶多酚制剂及其制备方法 | |
CN101129513B (zh) | 一种利用分离-制剂耦合技术制备益心酮缓释制剂的方法 | |
CN107556194A (zh) | 从金钱草中提取绿原酸的方法 | |
CN102000126B (zh) | 银杏黄酮片及其制备方法 | |
CN103372034A (zh) | 银杏叶提取物的制备方法 | |
CN102000123B (zh) | 银杏黄酮胶囊及其制备方法 | |
CN101190906B (zh) | 红花黄色素b的制备方法及其应用 | |
CN107375356B (zh) | 一种同时制备高纯度总黄酮醇苷和银杏内酯的方法 | |
CN102626427B (zh) | 一种银杏达莫组合物及其制剂的制备方法 | |
CN102018741B (zh) | 金盏银盘总黄酮提取物、制备工艺及其制剂 | |
CN100352457C (zh) | 一种罗布麻提取物的提取方法 | |
CN101396422B (zh) | 一种红车轴草提取物及其制备方法 | |
CN1335157A (zh) | 银杏黄酮、银杏内酯、白果内酯的系统分离方法及其制剂 | |
CN101780122B (zh) | 一种水溶性银杏提取物的制备方法 | |
CN101810663B (zh) | 芫根提取物用于制备减肥降血脂药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LIAONING XIANCAOTANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: JIANG ZHENMING Effective date: 20130926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130926 Address after: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee after: LIAONING XIANCAOTANG PHARMACEUTICAL CO., LTD. Address before: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee before: Jiang Zhenming |
|
ASS | Succession or assignment of patent right |
Owner name: JIANG ZHENMING Free format text: FORMER OWNER: LIAONING XIANCAOTANG PHARMACEUTICAL CO., LTD. Effective date: 20140523 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140523 Address after: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee after: Jiang Zhenming Address before: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee before: LIAONING XIANCAOTANG PHARMACEUTICAL CO., LTD. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20211013 Address after: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee after: Jiang Zhenming Patentee after: Chen Yiting Address before: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee before: Jiang Zhenming |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211129 Address after: 710031 room 10321, building 64, Huayu apartment, Zone D, South China City, international port district, Xi'an, Shaanxi Province Patentee after: Shaanxi Hanfang biopharmaceutical Co.,Ltd. Address before: Baoding City, Hebei province 071051 woodland Street No. 1099 Patentee before: Jiang Zhenming Patentee before: Chen Yiting |